Literature DB >> 10841980

Activation of nuclear factor-kB in the spinal cord of experimental allergic encephalomyelitis.

K Pahan1, M Schmid.   

Abstract

The DNA-binding activity of nuclear factor (NF-kB) was found to be induced in the spinal cord of rats with experimental allergic encephalomyelitis (EAE), an animal model of multiple sclerosis (MS), from the onset of the disease. This activation of NF-kB persisted throughout the disease period and decreased thereafter in the recovery phase. Supershift analysis of NF-kB DNA-binding activity in nuclear extracts of spinal cords showed that RelA/p65 and p50 subunits but not c-Rel/p75, RelB/p68 and p52 subunits were involved in DNA binding. Pyrrolidine dithiocarbamate (PDTC), an inhibitor of NF-kB activation, markedly inhibited the in vivo activation of NF-kB in the spinal cord of EAE rats and attenuated the clinical symptoms of EAE. These studies suggest that activation of NF-kB plays an important role in the pathogenesis of EAE and inhibitors of NF-kB activation may have therapeutic importance in MS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10841980     DOI: 10.1016/s0304-3940(00)01167-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

1.  Gender-specific expression of beta1 integrin of VLA-4 in myelin basic protein-primed T cells: implications for gender bias in multiple sclerosis.

Authors:  Saurav Brahmachari; Kalipada Pahan
Journal:  J Immunol       Date:  2010-05-05       Impact factor: 5.422

Review 2.  The Roles of Orphan G Protein-Coupled Receptors in Autoimmune Diseases.

Authors:  Mingming Zhao; Zheyu Wang; Ming Yang; Yan Ding; Ming Zhao; Haijing Wu; Yan Zhang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2021-01-07       Impact factor: 8.667

Review 3.  Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.

Authors:  Mythily Srinivasan; Debomoy K Lahiri
Journal:  Expert Opin Ther Targets       Date:  2015-02-04       Impact factor: 6.902

4.  Sodium benzoate, a food additive and a metabolite of cinnamon, modifies T cells at multiple steps and inhibits adoptive transfer of experimental allergic encephalomyelitis.

Authors:  Saurav Brahmachari; Kalipada Pahan
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

5.  Myeloid Kruppel-like factor 2 deficiency exacerbates neurological dysfunction and neuroinflammation in a murine model of multiple sclerosis.

Authors:  Hong Shi; Baiyang Sheng; Chao Zhang; Lalitha Nayak; Zhiyong Lin; Mukesh K Jain; G Brandon Atkins
Journal:  J Neuroimmunol       Date:  2014-07-04       Impact factor: 3.478

6.  Functional blocking monoclonal antibodies against IL-12p40 homodimer inhibit adoptive transfer of experimental allergic encephalomyelitis.

Authors:  Susanta Mondal; Avik Roy; Kalipada Pahan
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

7.  Adoptive transfer of immunomodulatory M2 macrophages suppresses experimental autoimmune encephalomyelitis in C57BL/6 mice via blockading NF-κB pathway.

Authors:  F Chu; M Shi; Y Lang; Z Chao; T Jin; L Cui; J Zhu
Journal:  Clin Exp Immunol       Date:  2021-02-01       Impact factor: 4.330

8.  LRP1 expression in microglia is protective during CNS autoimmunity.

Authors:  Tzu-Ying Chuang; Yong Guo; Scott M Seki; Abagail M Rosen; David M Johanson; James W Mandell; Claudia F Lucchinetti; Alban Gaultier
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

9.  Microarray analysis of tumor necrosis factor alpha induced gene expression in U373 human glioblastoma cells.

Authors:  Jens Schwamborn; Antje Lindecke; Margitta Elvers; Volker Horejschi; Martin Kerick; Mehran Rafigh; Julia Pfeiffer; Maria Prüllage; Barbara Kaltschmidt; Christian Kaltschmidt
Journal:  BMC Genomics       Date:  2003-11-25       Impact factor: 3.969

Review 10.  NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications.

Authors:  Saskia M Leibowitz; Jun Yan
Journal:  Front Mol Neurosci       Date:  2016-09-15       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.